Literature DB >> 35704066

[The anti-IgLON5 syndrome in clinical neurology-Report of two cases].

Johanna Niederschweiberer1, Nicolas U Schumacher2, Daniela Kumpfmüller3, Charlotte Lingg3, Simone Graf4, Benno Ikenberg2, Mark Mühlau2, Paul Lingor2, Bernhard Hemmer2,5, Benjamin Knier2.   

Abstract

Entities:  

Year:  2022        PMID: 35704066     DOI: 10.1007/s00115-022-01344-9

Source DB:  PubMed          Journal:  Nervenarzt        ISSN: 0028-2804            Impact factor:   1.214


× No keyword cloud information.
  2 in total

1.  Isolated rapid eye movement sleep behavior disorder and cyclic alternating pattern: is sleep microstructure a predictive parameter of neurodegeneration?

Authors:  Andrea Melpignano; Liborio Parrino; Joan Santamaria; Carles Gaig; Irene Trippi; Monica Serradell; Carlotta Mutti; Matteo Riccò; Alex Iranzo
Journal:  Sleep       Date:  2019-10-09       Impact factor: 5.849

2.  Clinical, serological and genetic predictors of response to immunotherapy in anti-IgLON5 disease.

Authors:  Thomas Grüter; Franziska E Möllers; Anja Tietz; Justina Dargvainiene; Nico Melzer; Anna Heidbreder; Christine Strippel; Andrea Kraft; Romana Höftberger; Florian Schöberl; Franziska S Thaler; Jonathan Wickel; Ha-Yeun Chung; Frank Seifert; Marlene Tschernatsch; Michael Nagel; Jan Lewerenz; Sven Jarius; Brigitte C Wildemann; Lucie de Azevedo; Fedor Heidenreich; Raphaela Heusgen; Ulrich Hofstadt-van Oy; Andreas Linsa; Jannis Justus Maaß; Til Menge; Marius Ringelstein; David J Pedrosa; Josef Schill; Thomas Seifert-Held; Caspar Seitz; Silke Tonner; Christian Urbanek; Simone Zittel; Robert Markewitz; Mirjam Korporal-Kuhnke; Thomas Schmitter; Carsten Finke; Norbert Brüggemann; Corinna I Bien; Ingo Kleiter; Ralf Gold; Klaus-Peter Wandinger; Gregor Kuhlenbäumer; Frank Leypoldt; Ilya Ayzenberg
Journal:  Brain       Date:  2022-03-08       Impact factor: 13.501

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.